Though both concern mostly M-CLL, the former displays a very aggressive clinical course similar to that of patients with TP53 aberrations, despite rarely carrying such lesions, thus sharply contrasting subset #4 that has emerged as the prototype of indolent CLL (120). Here, TP53 is linked to B-cell chronic lymphocytic leukemia.